Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This is a minor version update reflected in the page's revision history.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision number v3.6.4 has been added to the page. The previous revision v3.6.3 has been removed.SummaryDifference0.0%

- Check54 days agoChange DetectedDifference0.0%

- Check68 days agoChange DetectedNew sections and labels were added to the page’s help/navigation area, including No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. The revision tag was updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check75 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, indicating a minor update to the page version.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a platform/template release. It does not modify any study details or data on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.